Drug intelligence / Profile preview

BDR-934

Development stage
Preclinical
Lead developer
BioDrone Therapeutics
Modality
Gene Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

BDR-934 is a **preclinical cancer program** from **BioDrone Therapeutics** built on the company's **cell-derived vesicle** platform. It is described as a **DNA delivery** therapeutic using a **cell-derived vesicle nanocarrier/extracellular vesicle** approach to transport genetic material into tumor cells or immune cells with the aim of enabling therapeutic gene expression or biologic modulation in oncology. Publicly provided pipeline information identifies the asset as a Smart Drug Delivery program for **cancer**, but does not disclose a specific gene payload, molecular target, manufacturing configuration, route of administration, or branded product name.

Other names
BioDrone Therapeutics CDV DNA delivery program for cancercell-derived vesicle DNA delivery nanocarrier for cancer

Beyond the preview

Go deeper on BDR-934.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BDR-934.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call